Skip to main content

Table 5 Primary and secondary endpoints in the 1 year

From: Evaluation of the effectiveness and safety of preoperative drug elution balloon therapy in patients with elective tumor surgery and coronary heart disease: a retrospective clinical study

 

DEB group(n = 61)

DES group(n = 66)

P value

Primary outcome

 All cause death

2(3.3%)

9(13.6%)

0.038

 MACE

6(9.8%)

16(24.2%)

0.032

Fatal arrhythmias

2(3.3%)

6(9.1%)

0.326

 MI

1(1.6%)

8(12.1%)

0.051

 TLR

2(3.3%)

12(18.2%)

0.007

Secondary outcomes

 Bleeding events

0(0.0%)

6(9.1%)

0.046

 Venous thrombotic events

17(27.9%)

11(16.7%)

0.128

  1. MACE major adverse cardiac event, MI myocardial infarction, TLR target lesion revascularization
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us